TRK-IN-31
Product Specifications
Target
Trk receptor
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
TRK-IN-31 is an orally active TRK inhibitor with an IC50 of 1.8 nM. It demonstrates excellent antiproliferative activity in Ba/F3-MPRIP-TRKAG667C cells and selectively inhibits TRK kinase activity effectively. TRK-IN-31 also significantly suppresses tumor growth in a Ba/F3-MPRIP-TRKAG667C subcutaneous tumor mouse model.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog